Proliferation arrest in G1 phase of a non-small cell lung cancer cell line (NSCLC-N6) treated by an original compound methyl-4-methoxy-3-(3-methyl-2-butanoyl) benzoate (VT1) independently of the p53/p21 cascade.

International journal of oncology

Volumn 23, Issue 2, 2003, Pages 495-501

  Jacquot, Catherine ^a   Moreau, Dimitri ^a   Tomasoni, Christophe ^a   Juge, Marcel ^a   Coiffard, Laurence ^a   Roussis, Vasilios ^a   Roussakis, Christos ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALKENE; BENZOIC ACID DERIVATIVE; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE; ENZYME INHIBITOR; MESSENGER RNA; METHYL 4 METHOXY 3 (3 METHYL 2 BUTENOYL) BENZOATE; METHYL-4-METHOXY-3-(3-METHYL-2-BUTENOYL) BENZOATE; PROTEIN P53;

ARTICLE; CELL CULTURE; CELL CYCLE G1 PHASE; CELL DIVISION; COMPARATIVE STUDY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; PATHOLOGY;

ALKENES; BENZOATES; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; ENZYME INHIBITORS; G1 PHASE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 1542707160     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.23.2.495     Document Type: Article

References (0)